Investigating brain activity related to walking in Parkinson's patients
Official title: Investigating Neural Biomarkers for Gait in Parkinson's Patients
Run by Swiss Federal Institute of Technology · NCT05820074 · Data updated 2026-11-12
This study looks at how the brains of people with Parkinson's disease work while they walk to see if it can help create better treatments for their movement problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Swiss Federal Institute of Technology Academic / other |
| Locations | 1 site (Vitznau, Canton of Lucerne) |
| Status | Recruiting |
| Started | April 13, 2023 |
| Main results expected | March 2025 |
| Study ends | March 2025 |
| Registry record updated | December 3, 2024 |
| Trial ID | NCT05820074 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include non-tremor dominant idiopathic Parkinson's patients with postural instability and gait disturbances who have an implanted Percept™ PC neurostimulator.
✕Probably not a fit
Patients with relevant cognitive impairments or those with other neurological or orthopedic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the neural mechanisms involved in movement among individuals with Parkinson's disease. Participants will engage in walking and gait-related tasks while their brain activity is recorded to identify neural biomarkers associated with gait. The study includes 60 participants, split evenly between healthy individuals and those with Parkinson's disease, to compare neural activity during different motor tasks. Insights gained may lead to personalized treatment options for managing gait disorders in Parkinson's patients.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for gait disorders in Parkinson's disease.
How similar studies have gone: Other studies have shown promise in identifying neural biomarkers for movement disorders, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All participants * must have given informed consent as documented by signature * agree to comply with the study procedures Healthy control group * no neurological, orthopedic, or rheumatologic disease history * no identified sensory impairment. * no epilepsy and self-diagnosed acute or chronic psychiatric disorders Parkinson's Patients * non-tremor dominant idiopathic PD patients * presence of postural instability (UPDRS \>1 for postural instability \[17\]), gait disturbance, and absence of other causes of reduced balance * Implanted with Percept™ PC neurostimulator * Able to be in the stimulation OFF Exclusion Criteria: * Relevant cognitive impairment, with a score on Montréal Cognitive Assessment (MoCA) \< 20 * History of physical or neurological condition that interferes with study procedures * Social and/or personal circumstances interfering with the ability to come to the session
Where it's running
-
Cereneo
Vitznau, Canton of Lucerne, Switzerland Recruiting
Study contacts
- Principal investigator: Olivier Lambercy, PhD — RELab, ETH Zürich
- Study coordinator: Lena Salzmann, MSc
- Email: lena.salzmann@hest.ethz.ch
- Phone: +41788248679
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring how deep brain stimulation affects attention and freezing of gait in Parkinson's disease
This study tests how deep brain stimulation affects attention and helps reduce freezing of gait in people with Parkinson's disease.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.